Hankil Yoon insider trades
Open-market stock purchases and sales by Hankil Yoon, Director at Apimeds Pharmaceuticals US, Inc, from SEC Form 4 filings since May 16, 2025.
Companies traded
- APUS Apimeds Pharmaceuticals US, Inc: other filings, last Nov 11, 2025